230 related articles for article (PubMed ID: 3917885)
1. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
Steadham JE; Stall SK; Simmank JL
Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885
[TBL] [Abstract][Full Text] [Related]
2. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
Trimble KA; Clark RB; Sanders WE; Frankel JW; Cacciatore R; Valdez H
J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
Wallace RJ; Nash DR; Steele LC; Steingrube V
J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
5. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Akselband Y; Cabral C; Shapiro DS; McGrath P
J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
Texier-Maugein J; Mormède M; Fourche J; Bébéar C
Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
[TBL] [Abstract][Full Text] [Related]
7. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Thomas L; Naumann P; Crea A
Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
[TBL] [Abstract][Full Text] [Related]
9. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
Tsukamura M
Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
[TBL] [Abstract][Full Text] [Related]
10. Preliminary study of the in vitro activity of irloxacin against mycobacteria.
Casal M; Gutierrez J; Ruiz P; Moreno G
Chemotherapy; 1995; 41(3):204-7. PubMed ID: 7656667
[TBL] [Abstract][Full Text] [Related]
11. Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis.
Heifets LB; Iseman MD; Lindholm-Levy PJ
Antimicrob Agents Chemother; 1986 Dec; 30(6):927-32. PubMed ID: 3101588
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs.
Kuze F; Kurasawa T; Bando K; Lee Y; Maekawa N
Rev Infect Dis; 1981; 3(5):885-97. PubMed ID: 7339820
[TBL] [Abstract][Full Text] [Related]
13. New antimycobacterial S-alkylisothiosemicarbazones.
Waisser K; Heinisch L; Slosárek M; Janota J
Folia Microbiol (Praha); 2005; 50(6):479-81. PubMed ID: 16681143
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA
Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
[No Abstract] [Full Text] [Related]
15. Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks?
Malík I; Csöllei J; Solovič I; Pospíšilová Š; Michnová H; Jampílek J; Čížek A; Kapustíková I; Čurillová J; Pecháčová M; Stolaříková J; Pecher D; Oravec M
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274224
[TBL] [Abstract][Full Text] [Related]
16. Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii, and Mycobacterium gordonae directly from BACTEC TB broth cultures.
Reisner BS; Gatson AM; Woods GL
J Clin Microbiol; 1994 Dec; 32(12):2995-8. PubMed ID: 7883888
[TBL] [Abstract][Full Text] [Related]
17. Performance Assessment of the BluePoint MycoID Plus Kit for Identification of Mycobacterium tuberculosis, Including Rifampin- and Isoniazid-resistant Isolates, and Nontuberculous Mycobacteria.
Chien JY; Chang TC; Chiu WY; Yu CJ; Hsueh PR
PLoS One; 2015; 10(5):e0125016. PubMed ID: 25938668
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Davies S; Sparham PD; Spencer RC
J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
[TBL] [Abstract][Full Text] [Related]
19. [Utility of the direct culture examination (Ziehl-Neelsen) using the Bactec system for the presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium xenopi, and Mycobacterium kansasii].
Moreno C; Garrigó M; Sánchez F; Coll P
Enferm Infecc Microbiol Clin; 1994 May; 12(5):241-5. PubMed ID: 7811323
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis.
Ardito F; Sanguinetti M; Sechi L; Posteraro B; Masucci L; Fadda G; Zanetti S
New Microbiol; 2000 Apr; 23(2):151-8. PubMed ID: 10872685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]